Clinical Trial Update: The Impact of ERA Switching on Risk Stratification in Pulmonary Arterial Hypertension

View source ↗

Summary

This clinical trial update describes a study assessing the impact of switching endothelin receptor antagonists on risk stratification in pulmonary arterial hype…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension (PAH) | Status: RECRUITING